HER2 Positive Untreated Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch HER2 Positive Untreated Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer (NCT02598427) | Kimberly Blackwell | 2017-05-01 |
Track HER2 Positive Untreated Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.